About Medicoremedies
Medicoremedies is a company. The company has 70 employees as of April 09, 2024. Medicoremedies offers products and services including Anti-Infectives and Vitamins and Supplements.
- Employees 70 as on 09 Apr, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Medico Remedies Limited
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$17.18 M (USD)1.85as on Mar 31, 2024
-
Net Profit
$968.57 K (USD)14.49as on Mar 31, 2024
-
EBITDA
$1.51 M (USD)34.19as on Mar 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
70
as on Apr 09, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Medicoremedies
Medicoremedies is a publicly listed company on the NSE with ticker symbol MEDICO in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Medicoremedies
Medicoremedies offers a comprehensive portfolio of products and services, including Anti-Infectives and Vitamins and Supplements.
Formulations for treating infections are produced by the company.
Vitamins, haematinics, and other supplements are manufactured and marketed for therapeutic uses.
Funding Insights of Medicoremedies
Detailed funding history for Medicoremedies
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Medicoremedies
Investment portfolio details for Medicoremedies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Medicoremedies
Detailed financials for Medicoremedies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Medicoremedies Comparisons
Peer comparison for Medicoremedies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Medicoremedies
Detailed competitors of Medicoremedies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Medicoremedies
Complete news archive for Medicoremedies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medicoremedies
As of Apr 09, 2024, the latest employee count at Medicoremedies is 70.
Annual revenue of Medicoremedies is $17.18M as on Mar 31, 2024.
Operations in the pharmaceutical sector are centered on the production and distribution of formulations, including beta-lactams, cephalosporins, antimalarials, antiretrovirals, anti-ulcer drugs, antacids, vitamins, haematinics, supplements, NSAIDs, antihistamines, anti-diabetics, cardiovascular drugs, diuretics, anti-epileptics, combination kits, syrups, creams, and gels. Focus is placed on diverse therapeutic areas, with capabilities extending to marketing across multiple segments.
Medicoremedies offers Anti-Infectives and Vitamins and Supplements.
Yes, Medicoremedies is publicly traded on NSE under the ticker symbol MEDICO.
The ticker symbol of Medicoremedies is MEDICO on NSE.